APA (7th ed.) Citation

MM, E., & MM, A. (2025). Safety profile of glucokinase activator AZD1656: Systematic review and meta-analysis of 23 randomised trials in diabetic and healthy volunteers with relevance to immunomodulatory therapy. Inflammopharmacology, 33(8), 4671. https://doi.org/10.1007/s10787-025-01785-z

Chicago Style (17th ed.) Citation

MM, Elsayed, and Abdalla MM. "Safety Profile of Glucokinase Activator AZD1656: Systematic Review and Meta-analysis of 23 Randomised Trials in Diabetic and Healthy Volunteers with Relevance to Immunomodulatory Therapy." Inflammopharmacology 33, no. 8 (2025): 4671. https://doi.org/10.1007/s10787-025-01785-z.

MLA (9th ed.) Citation

MM, Elsayed, and Abdalla MM. "Safety Profile of Glucokinase Activator AZD1656: Systematic Review and Meta-analysis of 23 Randomised Trials in Diabetic and Healthy Volunteers with Relevance to Immunomodulatory Therapy." Inflammopharmacology, vol. 33, no. 8, 2025, p. 4671, https://doi.org/10.1007/s10787-025-01785-z.